Capital Analysts LLC’s Solventum SOLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12K Buy
158
+10
+7% +$729 ﹤0.01% 1264
2026
Q1
$10K Hold
148
﹤0.01% 1263
2025
Q4
$12K Hold
148
﹤0.01% 1221
2025
Q3
$11K Hold
148
﹤0.01% 1196
2025
Q2
$11K Hold
148
﹤0.01% 1136
2025
Q1
$11K Sell
148
-8
-5% -$596 ﹤0.01% 1116
2024
Q4
$10K Sell
156
-42
-21% -$2.94K ﹤0.01% 1065
2024
Q3
$14K Hold
198
﹤0.01% 974
2024
Q2
$10K Buy
+198
New +$12K ﹤0.01% 961

Other funds holding SOLV

Capital Analysts LLC's SOLV Position: Q2 2026 in Review

Capital Analysts LLC increased its Solventum (SOLV) stake by 6.8% in Q2 2026, buying an estimated $729 and bringing the position to 158 shares worth $12K. The position accounts for ﹤0.01% of the portfolio, ranked #1264.

Capital Analysts LLC first reported a position in SOLV in Q2 2024 and has held it in 9 quarters since. The position peaked at $14K in Q3 2024. 875 funds tracked by Wall St. Rank hold SOLV as of Q2 2026.

  • Capital Analysts LLC held 158 shares of Solventum worth $12K as of Q2 2026.
  • Capital Analysts LLC bought 10 Solventum shares in Q2 2026, an estimated $729.
  • Solventum made up ﹤0.01% of Capital Analysts LLC's portfolio in Q2 2026, its #1264 holding.
  • Capital Analysts LLC first reported a position in Solventum in Q2 2024 and has held it in 9 quarters since.
  • Capital Analysts LLC's Solventum position peaked at $14K in Q3 2024.
  • 875 funds tracked by Wall St. Rank held Solventum as of Q2 2026.

Based on Capital Analysts LLC's 13F filing for Q2 2026, filed 5 Aug 2026.